Mar
26
2020
Interferon alfa-2b recombinant vs Coronavirus (Covid19)
In the urgent pursuit of effective therapies against the aggressive Coronavirus (Covid19) disease, the People´s Republic of China applied different treatment schemes in medical practice such as the case of the Interferon alfa-2b recombinant, together with a range of other antiretroviral. This practice has also been recommended by the Chinese Pharmacological Society Experts Consensus, the Johns Hopkins Medical Center Guides in Baltimore, a Technical Document from the Ministry of Health of Spain, among others from different countries and international organizations.
